Daniel Koller: Three decades of biotech evolution

US still offering the most biotech names

clock • 4 min read

Over the past three decades, the biotech industry has witnessed remarkable growth and advances in drug development.

While 30-years ago biotechnology was a very young industry with a few dominant players such as Genentech, Amgen and Biogen, there is now a broad mix of large companies, start-ups and smaller providers with research and development candidates. European Assets appoints International Biotech trust chair to its board Then, as now, the US had the largest number of investable listed and private biotech companies and remains by far the most developed market for biotech investments today. Listed biotech companies in US and Europe today achieve revenues of over $200bn, which corresponds to ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment

Over a quarter of younger investors own crypto as overall optimism on the rise in July

Over a quarter of younger investors own crypto as overall optimism on the rise in July

Optimism up from May figures

Sorin Dojan
clock 23 July 2025 • 2 min read
Partner Podcast: What clients really want from their managers

Partner Podcast: What clients really want from their managers

Listen to the latest postcast with Honor Solomon, CEO for EMEA and Head of EMEA Retail Sales, at AllianceBernstein

Honor Solomon, CEO for EMEA and Head of EMEA Retail Sales, at AllianceBernstein
clock 22 July 2025 • 1 min read
Dimensional's Kaitlin Hendrix: Counting the cost of index rebalancing

Dimensional's Kaitlin Hendrix: Counting the cost of index rebalancing

Reconstitutions can hurt returns

Kaitlin Hendrix
clock 18 July 2025 • 4 min read
Trustpilot